With an accuracy of 86%, the biomarker panel has the potential to be clinically useful in diagnosis, management, and ...
Measuring the levels of vitronectin in urine could improve the detection of kidney fibrosis, according to scientists from the ...
The model was based on a panel of 12 urinary proteins linked to renal inflammation and outperformed clinically available biomarkers such as C3, C4, anti-dsDNA, and UPCR, Dr Fava’s team reported. The 3 ...
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Kidney Cancer Session II. Dr Mark Ball discussed ...
An ideal biomarker of AKI should identify the ... there is still space for a functional marker on any future kidney biomarker panel. When combined with some of the renal biomarkers mentioned ...
faced several challenges in identifying novel safety biomarkers in the renal setting. The kidney is a major site of organ damage caused by drug toxicity. This frequently manifests during drug ...
cystatin C and kidney injury molecule-1, are being intensively investigated. Until a highly sensitive and specific panel of biomarkers that can be easily used in practice has been validated ...
Measuring the levels of vitronectin in urine could improve the detection of kidney fibrosis, according to scientists from the Germans Trias i Pujol Research Institute (IGTP) and University ...